CRC
Curi RMB Capital Portfolio holdings
AUM
$5.27B
1-Year Return
16.35%
This Quarter Return
-6.43%
1 Year Return
+16.35%
3 Year Return
+64.1%
5 Year Return
+119.5%
10 Year Return
+234.7%
AUM
$3.16B
AUM Growth
-$151M
(-4.6%)
Cap. Flow
+$95M
Cap. Flow
% of AUM
3%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
464
New
11
Increased
187
Reduced
134
Closed
29
Top Buys
| 1 |
S&P Global
SPGI
|
$49.4M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$27.9M |
| 3 |
FRC
First Republic Bank
FRC
|
$11.4M |
| 4 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
$10.2M |
| 5 |
Walt Disney
DIS
|
$9.55M |
Top Sells
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$55.1M |
| 2 |
CERN
Cerner Corp
CERN
|
$16.3M |
| 3 |
Progressive
PGR
|
$13.4M |
| 4 |
Steris
STE
|
$9.64M |
| 5 |
Edwards Lifesciences
EW
|
$7M |
Sector Composition
| 1 | Technology | 19.11% |
| 2 | Financials | 16.39% |
| 3 | Healthcare | 15.48% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Camden Property Trust
CPT
$11.9B
| $683K | 0.02% |
4,107
+25
| +0.6% | +$4.16K |
|
302
Independent Bank
INDB
$3.55B
| $682K | 0.02% |
8,347
| – | – |
|
303
iShares Select Dividend ETF
DVY
$20.8B
| $676K | 0.02% |
5,272
+551
| +12% | +$70.7K |
|
304
State Street
STT
$32B
| $668K | 0.02% |
7,666
+19
| +0.2% | +$1.66K |
|
305
Walmart
WMT
$801B
| $661K | 0.02% |
13,311
-714
| -5% | -$35.5K |
|
306
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
| $652K | 0.02% |
29,851
| – | – |
|
307
Intel
INTC
$107B
| $651K | 0.02% |
13,126
+30
| +0.2% | +$1.49K |
|
308
Energy Transfer Partners
ET
$59.7B
| $649K | 0.02% |
58,042
+5,834
| +11% | +$65.2K |
|
|
TSVT
309
DELISTED
2seventy bio
TSVT
| $649K | 0.02% |
38,014
| – | – |
|
310
Nike
NKE
$109B
| $646K | 0.02% |
4,798
-925
| -16% | -$125K |
|
311
Procter & Gamble
PG
$375B
| $638K | 0.02% |
4,179
-635
| -13% | -$96.9K |
|
312
Goldman Sachs
GS
$223B
| $635K | 0.02% |
1,925
-234
| -11% | -$77.2K |
|
313
Crown Castle
CCI
$41.9B
| $632K | 0.02% |
3,422
-75
| -2% | -$13.9K |
|
314
Robert Half
RHI
$3.77B
| $616K | 0.02% |
5,393
| – | – |
|
315
Hubbell
HUBB
$23.2B
| $599K | 0.02% |
+3,258
| New | +$599K |
|
316
AstraZeneca
AZN
$253B
| $594K | 0.02% |
8,960
+687
| +8% | +$45.5K |
|
317
Rockwell Automation
ROK
$38.2B
| $590K | 0.02% |
2,106
| – | – |
|
318
Iovance Biotherapeutics
IOVA
$901M
| $579K | 0.02% |
34,791
+7,453
| +27% | +$124K |
|
319
American Express
AXP
$227B
| $568K | 0.02% |
3,039
-1,750
| -37% | -$327K |
|
320
Waste Management
WM
$88.6B
| $561K | 0.02% |
3,542
+2
| +0.1% | +$317 |
|
321
Veracyte
VCYT
$2.55B
| $558K | 0.02% |
20,239
| – | – |
|
322
Targa Resources
TRGP
$34.9B
| $551K | 0.02% |
7,301
| – | – |
|
|
ABMD
323
DELISTED
Abiomed Inc
ABMD
| $544K | 0.02% |
1,643
-72
| -4% | -$23.8K |
|
324
Gilead Sciences
GILD
$143B
| $532K | 0.02% |
8,946
-29
| -0.3% | -$1.73K |
|
325
Berkshire Hathaway Class A
BRK.A
$1.08T
| $529K | 0.02% |
1
| – | – |
|